Total Funding
71
60
Total FundingSeries B raised
Growth Score 71 in past quarter
-15 pts
Heat Score 60 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
17020
Gate Bioscience is a biotechnology company that specializes in a small molecule modality to treat biology’s intractable diseases.
- Jordi Mata-Fink: Co-Founder and CEOPast Role: Cygnal Therapeutics, Founder & CTO
Raman Talwar: Co-Founder & CTOPast Role: Third Rock Ventures, Consultant
About the Company
Gate Bioscience is a biotechnology company that specializes in a small molecule modality to treat biology’s intractable diseases. The company pioneers a novel therapeutic modality called Molecular Gates, small-molecule drugs that selectively block and eliminate disease-causing proteins before they are secreted. Their discovery platform combines a
library of privileged gate molecules, specialized assays focused on protein secretion, and deep biological insights into the secretory translocon (Sec61) pathway. By binding to the secretory channel of specific target proteins, molecular gates prevent their export and cause their intracellular degradation, which could provide oral, highly selective therapies.
